Evidence map›Paper›PMID 26074812›Full record

ArticleFrontiers in aging neuroscience2015

Myogenic-specific ablation of Fgfr1 impairs FGF2-mediated proliferation of satellite cells at the myofiber niche but does not abolish the capacity for muscle regeneration.

Zipora Yablonka-Reuveni, Maria E Danoviz, Michael Phelps, Pascal Stuelsatz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The muscle stem cell niche at a glance.Journal of cell science · 2023
    Article
  9. Review
  10. Review
  11. Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. FGF/FGFR signaling in health and disease.Signal transduction and targeted therapy · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zipora Yablonka-ReuveniDepartment of Biological Structure, University of Washington School of Medicine, Seattle WA, USA.
Maria E DanovizDepartment of Biological Structure, University of Washington School of Medicine, Seattle WA, USA.
Michael PhelpsDepartment of Biological Structure, University of Washington School of Medicine, Seattle WA, USA.
Pascal StuelsatzDepartment of Biological Structure, University of Washington School of Medicine, Seattle WA, USA.
University of Washington · US

Funding

GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
Myogenic Stem Cell Function in Aging Skeletal MuscleR01AG021566 · NIA · UNIVERSITY OF WASHINGTON · PI YABLONKA-REUVENI, ZIPORA · 2002 to 2012
$3.6M
Satellite Cells and Skeletal Muscle Growth DynamicsR01AG013798 · NIA · UNIVERSITY OF WASHINGTON · PI YABLONKA-REUVENI, ZIPORA · 1995 to 2008
$1.8M
Myogenic stem cells in extraocular musclesR01AG035377 · NIA · UNIVERSITY OF WASHINGTON · PI YABLONKA-REUVENI, ZIPORA · 2009 to 2014
$1.6M
Can klotho alleviate muscle fibrosis in muscular dystrophy?R21NS090051 · NINDS · UNIVERSITY OF WASHINGTON · PI YABLONKA-REUVENI, ZIPORA · 2014 to 2015
$425k
NIA NIH HHS R01 AG013798NIA NIH HHS R01 AG021566NIA NIH HHS R01 AG035377NIA NIH HHS T32 AG000057NINDS NIH HHS R21 NS090051
6 · The paper itself

Abstract

Skeletal muscle satellite cells (SCs) are Pax7(+) myogenic stem cells that reside between the basal lamina and the plasmalemma of the myofiber. In mature muscles, SCs are typically quiescent, but can be activated in response to muscle injury. Depending on the magnitude of tissue trauma, SCs may divide minimally to repair subtle damage within individual myofibers or produce a larger progeny pool that forms new myofibers in cases of overt muscle injury. SC transition through proliferation, differentiation and renewal is governed by the molecular blueprint of the cells as well as by the extracellular milieu at the SC niche. In particular, the role of the fibroblast growth factor (FGF) family in regulating SCs during growth and aging is well recognized. Of the several FGFs shown to affect SCs, FGF1, FGF2, and FGF6 proteins have been documented in adult skeletal muscle. These prototypic paracrine FGFs transmit their mitogenic effect through the FGFRs, which are transmembrane tyrosine kinase receptors. Using the mouse model, we show here that of the four Fgfr genes, only Fgfr1 and Fgfr4 are expressed at relatively high levels in quiescent SCs and their proliferating progeny. To further investigate the role of FGFR1 in adult myogenesis, we have employed a genetic (Cre/loxP) approach for myogenic-specific (MyoD(Cre)-driven) ablation of Fgfr1. Neither muscle histology nor muscle regeneration following cardiotoxin-induced injury were overtly affected in Fgfr1-ablated mice. This suggests that FGFR1 is not obligatory for SC performance in this acute muscle trauma model, where compensatory growth factor/cytokine regulatory cascades may exist. However, the SC mitogenic response to FGF2 is drastically repressed in isolated myofibers prepared from Fgfr1-ablated mice. Collectively, our study indicates that FGFR1 is important for FGF-mediated proliferation of SCs and its mitogenic role is not compensated by FGFR4 that is also highly expressed in SCs.

Indexed as

alpha7 integrincardiotoxin injuryfibro/adipogenic progenitorsfibroblast growth factormuscle spindlesMyoDCrePax7satellite cells

Identifiers

PMID26074812
PMCPMC4446549
OpenAlexW1569463737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.